Towards the Establishment of a Biomedical Ontology for the Primary Sjögren’s Syndrome

Primary Sjögren’s Syndrome (pSS) has been characterized as a hypersensitivity reaction type II systemic autoimmune chronic disease causing exocrine gland dysfunction mainly affecting women near the menopausal age. pSS patients exhibit dryness of the main mucosal surfaces and are highly prone to lymphoma development. This paper presents a first biomedical ontology for pSS based on a reference model which was determined by pSS clinical experts. The ensuing ontology constitutes the fundamental basis for mapping pSS-related ontologies from international cohorts to a common ontology. The ontology mapping (i.e., schematic interlinking) procedure is, in fact, a preliminary step to harmonize heterogeneous medical data obtained from various cohorts.

[1]  Athanasios G. Tzioufas,et al.  Topical and systemic medications for the treatment of primary Sjögren's syndrome , 2012, Nature Reviews Rheumatology.

[2]  Gang Feng,et al.  Disease Ontology: a backbone for disease semantic integration , 2011, Nucleic Acids Res..

[3]  Markus Perola,et al.  Data harmonization and federated analysis of population-based studies: the BioSHaRE project , 2013, Emerging Themes in Epidemiology.

[4]  J. Melki,et al.  Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome. , 2013, Blood.

[5]  Xavier Mariette,et al.  Sjögren Syndrome‐associated lymphomas: an update on pathogenesis and management , 2015, British journal of haematology.

[6]  P. Ravaud,et al.  EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome , 2011, Annals of the rheumatic diseases.

[7]  Philippe Ravaud,et al.  EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide , 2015, RMD Open.

[8]  H. Moutsopoulos,et al.  Lymphoma development in Sjögren's syndrome: novel p53 mutations. , 1999, Arthritis and rheumatism.

[9]  M. Koutsilieris,et al.  B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome. , 2014, Journal of autoimmunity.

[10]  Yinon Shapira,et al.  Geoepidemiology of autoimmune rheumatic diseases , 2010, Nature Reviews Rheumatology.

[11]  Claire Bombardier,et al.  Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS‐RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA‐WIS), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Qu , 2011, Arthritis care & research.

[12]  S. Clair,et al.  Recent advances in primary Sjogren ' s syndrome , 2018 .

[13]  Wei Zhang,et al.  Validity of the work productivity and activity impairment questionnaire - general health version in patients with rheumatoid arthritis , 2010, Arthritis research & therapy.

[14]  P. Pisa,et al.  High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients , 1991, The Journal of experimental medicine.

[15]  Belchin Kostov,et al.  Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. , 2015, Autoimmunity reviews.